Zivo Bioscience, Inc. · OTC:ZIVO
Zivo Bioscience — Biotech Showcase 2018
24 slides from Zivo Bioscience's conference presentation, Jan 10, 2018
Slide 1: Unprecedented Insights into Personal Health
EXHIBIT 99.1 wellmetrix Unprecedented Insights [nell ef eye} ate La Hello. My name is Andrew Dahl. I’m here to talk about insights into personal health that can benefit us all.
Slide 2: Better Health: Everyone's Invested
Better Health: Everyone’s Invested Governments Premiums i Competitive edge Anticipate problems Silver tsunami Manage outcomes Cost of care __ Slow spending increases Productivity Out-of-pocket expenses Efficiency Longevity Individuals wv wellmetrix. The healthcare sector represents nearly a quarter
Slide 3: Wellness in the Workplace and Beyond
Wellness in the Workplace and Beyond 34% of 128 million US workers at greater risk for Big 4 — but which ones — specifically? 41 million employees at higher risk, . but which ~75% of national healthcare spend ones? due to avoidable, lifestyle-induced problems CANCER Millions more outside the network
Slide 4: Wellness in the Workforce and Beyond
Wellness in the Workforce and Beyond 128M Diagnostics, HRA’s and vital signs don’t measure healthiness or : metabolic efficiency 441M Wearable devices record only ‘Test 4 activities and anecdotes Intervene Public Health Programs need better tools, too wellmetrix. For insured groups or population hea
Slide 5: The Health Risk Assessment Conundrum
The Health Risk Assessment Conundrum HRA Input Age 55 55 Weight +30 +30 Smoker NO NO Alcohol 1/Day 1/Day Drugs NO NO Exercise YES YES 85/120 6.8 200+ Blood Pressure 85/120 AIC 6.8 Cholesterol 200+ Bill wwe wellmetrix. Let’s take a look at Bill and Phil, both 55 years old, 30 plus pounds overweight a
Slide 6: You Can't Fix What You Can't Measure
You Can't Fix What You Can’t Measure HRA Reality Age 55 55 Weight +30 1 +30 Smoker NO 1-Pack/day | | NO Alcohol 1/Day | Siday j 1/Day Drugs NO Cannabis NO Exercise YES NO YES Blood Pressure 85/120 85/120 A1C 6.8 6.8 Cholesterol 200+ 200+ Phil ae wellmetrix. The reality is a little different and unfo
Slide 7: You Can't Fix What You Can't Measure
You Can’t Fix What You Can’t Measure wellmetrix. Nominal Metabolic Profile Lipid Perox 30-50 120-180 AntiOx Cap 40 15 Inflammation 20-30 70-90 Ketones 0 Trace Hydration 50 20-25 pH 7.0 6.4 Energy 60-80 40-60 Bill si wellmetrix. An individual’s response to poor lifestyle choices is highly variable an
Slide 8: New Metrics, New Approach
New Metrics, New Approach wellmetrix. Nominal VY Metabolic Profile Lipid Perox 30-50 « AntiOx Cap 40 ca Inflammation 20-30 € Ketones 0 Hydration 50 @ pH 7.0 Energy 60-80 vw wellmetrix. Our metabolic test panel indicates that Phil’s under stress, his metabolism isn’t as efficient and therefore, less
Slide 9: Why Is Any of This Important?
Why Is Any of This Important? Risk of The best way to lower healthcare costs is to Stroke avoid them in the first place Diabetes ig igi 5 git Cancer, Specifics, not statistics — individual response to stressors A trove of new data, insights and analytics Premi Absenteeism Anticipate pre S productivi
Slide 10: WellMetrix — Unprecedented Insights into Personal Health
WellMetrix — Unprecedented Insights into Personal Health Bluetooth Analyzer / Non-invasive, inexpensive POC Disposable Test Cartridge urine test, analyzer and app Track health status with positive lifestyle changes Monitor pre-conditions for future health issues Mobile or WY Tablet App vw wellmetrix
Slide 11: WellMetrix — Unprecedented insights into personal health
WellMetrix — Unprecedented insights into personal health Results in 3 minutes Hydration Antioxidant Capacity Oxidative Stress Biomarkers ‘: “ Muscle Recover’ Systemic Inflammation iJ Electrol ~ Energy In Home, Office, Shop or Walk-in Clinic Settings wellmetrix to display, store and compile test resu
Slide 12: Price/Performance Breakthrough
Price/Performance Breakthrough Next-gen metabolic markers in a proven format Integrate data from other health tracking devices No labs. No wait. No mess. Low cost. Per test ww wellmetrix We use a standard urine strip format, replacing diagnostic chemistry with metabolic marker assays. We can pull in
Slide 13: Business Model — Workplace Wellness
Business Model — Workplace Wellness Disposable tests cost $2 sell for $14 Analyzers cost $50 sell for $100 Razor/Blade Model Private label to wellness consultants, insurers, screening companies, ACO’s Focus on Execution 70% ~24m $521 US companies Wellness screening Estimated per- provide WW Tests an
Slide 14: Market Traction
Market Traction WellMetrix teams with industry pioneers LOI from Trion Solutions to purchase 15,000 WellMetrix tests Workplac: Ss Pilot programs with 5 HMO’s for Other Applications Medicaid population study Letter of recommendation from director of state department of health ww wellmetrix WellMetrix
Slide 15: Senior In-Home Care
Senior In-Home Care 13,000 Providers serving 4.7M Seniors $14/test to provider on monthly or bi-weekly schedule Medicare billing code exists Connected Heatth for the Sifver Tsunami wellmetrix Senior-In-Home Care is growing rapidly and Medicare encourages aging in place. But, care is provided by mini
Slide 16: Consumer Personal Health Tracking
Consumer Personal Health Tracking Private label kits to channel partners for lowest market-entry risk Speed to market, accelerate adoption Professional Reseller Channels . Fitness Centers Personal Coaches Retail kit for affluent, informed early adopters Medical Spas Weight Loss Clinics rane he tee a
Slide 17: Market Verticals
Market Verticals ~$500M VW ~$250M W ~$250M Workplace Senior In-Home Consumer Wellness Care Personal Health These are not generalized market vertical numbers. This is where we can expect to be in term of revenue once fully deployed in these market verticals over time. And we have a detailed plan avai
Slide 18: Competition
Competition Them Biomarkers 1 Modality Lab/DIY Format Dry Assay [Rus Chemistry Cost $14 Up to $171 Data Normalize Yes No Mobile App Yes No Instant Results Yes No Biohazard fe) Yes we wellmetrix. Directly competitive tests do exist, but typically as single analyte, wet-chemistry tests. Most are expen
Slide 19: Development Milestones
Development Milestones [o 25% 50% 75% 100% | Optics, circuitry, firmware, analyzer, collection device design, CAD, alpha prototypes | | Biomarker assay development, testing, norming [ Betas, soft tooling, production-intent low volume runs, mobile app development LJ Final CAD, hard tooling, first run
Slide 20: Executive Biographies
Executive Biographies Andrew A. Dahli David Bucknam Kerry W. Wilson President & CEO Vice President of Operations, Compliance Director, Engineering & Project Management Amy E. Steffek PhD Phillip M. Rice Il Director, Research & Development Chief Financial Officer Owen Resh Director of Marketing and D
Slide 21: $12M Post-Seed Round
$12M Post-Seed Round To date, $4M invested to secure/develop IP, build prototypes and test the market = $2Million Finalize development, soft tools to build 5,000 test kits for evaluation/pilots <a $10Million Hard-tooling, compliance, inventory build, operating expense and market launch we wellmetrix
Slide 22: Outlook
Outlook Yearly Revenues in (000) 300000 Potential Revenues by 250000 Market Vertical, fully 200000 deployed 150000 $500M Health & Wellness $250M Senior In-Home $250M Personal Health 50000 100000 0 Year 2 Year 3 Year4 www wellmetrix When framed against 128 million employees plus their dependents, the
Slide 23: Summary
Summary A price-performance first in personal wellness Novel, well-protected IP timed to exploit trends in personal wellness Rapidly scalable operational model wellmetrix A few parting thoughts: Most of the people gathered here are focused on the 5% of the population that are sick. We’re focused on
Slide 24: wellmetrix
wellmetrix Unprecedented Insights Contact: Andrew A. Dahl E: adah|@wellmetris.com M: 1 248 978 3911 Into Personal Health 24